Who invested in Travanti Pharma?
Travanti Pharma's investors include Prolog Ventures and Spring Bay Ventures.
United States · Series B startup
One round we have observed, with the 2 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$7.5Mraised across 1 round since 2006, from 1 source
Travanti Pharma's investors include Prolog Ventures and Spring Bay Ventures.
Travanti Pharma has raised $7.5M across 1 round since 2006.
Travanti Pharma's most recent round was a Series B of $7.5M in Jul 2006.
Its most recent round, $7.5M in Jul 2006, is also its largest on record.
Travanti Pharma's first round on record, in Jul 2006, was backed by Prolog Ventures and Spring Bay Ventures.
Travanti Pharma's latest named round is a Series B, in Jul 2006.
Travanti Pharma is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.